Thanks to @FionaRMischel & the @SynBioBeta podcast for great convo exploring "How DNA Will Make Our Future?" We explored why we make DNA and what role these fundamental molecules will play in the future of the bioeconomy. More: ow.ly/amV350KroMT
#DNAsynthesis #syntheticDNA
In @ForbesTechCncl, @DNAScript's @SylvainGariel talks about something he calls “assay streaming,” enabling facilities distributed globally to produce a standardized assay in response to an emerging biothreat the moment the assay is validated. Read more: ow.ly/MOSl50KkilL
Thomas YBERT retweeted
Today we announced the first successful #qPCR assays using primers & probes, synthesized via #EnzymaticSynthesis using #SYNTAX, for the detection of infectious disease and biothreats. This was achieved in liaison with the @DGA. More: ow.ly/QMBn50JJt2K
#DNAonDemand
Today we launched next-gen kits for same-day #qPCR from design to results, as well as other #genomics applications. With the printing of longer oligos and labeled probes, these advances promise to expedite workflows to accelerate discovery!
ow.ly/L0Ib50Jqm5S
@agbt #AGBT2022
Thomas YBERT retweeted
Welcome #lifescience veteran @chrisbarbazette as our new Chief Commercial Officer. He will play a pivotal role in driving our continued commercial growth. We're thrilled he has joined the team! More: ow.ly/PLV050J3RVw
#biotech #leadership #enzymaticDNAsynthesis #DNAonDemand
Thomas YBERT retweeted
Keep your eyes on this field-epigentics is going to offer us a lot in the way of diagnosis and treatment in the... fb.me/1jLyVrJ0o
